Predictive Oncology Inc. (POAI)
| Market Cap | 81.76M |
| Revenue (ttm) | 1.41M |
| Net Income (ttm) | -24.79M |
| Shares Out | 51.58M |
| EPS (ttm) | -0.82 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,549,600 |
| Open | 1.22 |
| Previous Close | 1.27 |
| Day's Range | 1.18 - 1.26 |
| 52-Week Range | 0.63 - 2.30 |
| Beta | 1.78 |
| Analysts | Buy |
| Price Target | 4.50 (+260.0%) |
| Est. Earnings Date | Nov 15, 2021 |
About POAI
Predictive Oncology Inc. provides various healthcare products and services primarily in the United States. The company operates in three segments: Helomics, Soluble, and Skyline. The company manufactures environmentally conscious systems for the collection and disposal of infectious fluids that result from surgical procedures and post-operative care. It offers STREAMWAY System, a wall-mounted fully automated system that disposes suction fluid providing uninterrupted performance for physicians while virtually eliminating healthcare workers' expo...
Financial Performance
In 2020, POAI's revenue was $1.25 million, a decrease of -11.28% compared to the previous year's $1.41 million. Losses were -$25.88 million, 33.5% more than in 2019.
Financial StatementsAnalyst Forecast
According to 2 analysts, the average rating for POAI stock is "Buy." The 12-month stock price forecast is 4.50, which is an increase of 260.00% from the latest price.
News
Predictive Oncology Launches Website Highlighting AI-Powered Cancer Research Advancements
Predictive Oncology is leveraging AI to streamline drug discovery and development, improve outcomes in clinical testing and forge a new frontier of cancer research Predictive Oncology is leveraging AI t...
Are Penny Stocks Worth Buying? Check These 3 Out Right Now
Three penny stocks that you should know about in October 2021 The post Are Penny Stocks Worth Buying? Check These 3 Out Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | Pen...
Hot Penny Stocks to Watch In the Last Week of September
Making a list of penny stocks to buy next month? Check these three out The post Hot Penny Stocks to Watch In the Last Week of September appeared first on Penny Stocks to Buy, Picks, News and Information...
Do These Penny Stocks Deserve a Place On Your Watchlist?
Why investors are watching these penny stocks right now The post Do These Penny Stocks Deserve a Place On Your Watchlist? appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks...
Predictive Oncology Announces Results of Charter Amendment Proposal at Special Meeting
MINNEAPOLIS, Aug. 18, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology (Nasdaq: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discove...
Predictive Oncology Reports Financial Results for Quarter Ended June 30, 2021, and Provides Business Update
MINNEAPOLIS, Aug. 11, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology (Nasdaq: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discove...
Predictive Oncology Adjourns Special Meeting of Stockholders
MINNEAPOLIS, Aug. 11, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology (Nasdaq: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discove...
Predictive Oncology subsidiary, Helomics uses data from the 100,000 Genomes Project to better predict ovarian cancer ...
Initial results demonstrate that AI models of genomic data can predict cancer outcomes. This has the potential to help personalize ovarian cancer treatments and drive the discovery of new therapies. Ini...
Best Penny Stocks For Your July 2021 List? 8 Biotechs To Watch Now
Current & former penny stocks to watch if you like biotech right now. The post Best Penny Stocks For Your July 2021 List?
Predictive Oncology Inc.'s Subsidiaries Soluble Biotech Inc. and TumorGenesis Inc. are both constructing new GMP labs
MINNEAPOLIS, June 22, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology (NASDAQ: POAI), an AI-driven oncology and drug discovery company, announced today that two of their wholly owned subsidiaries, Soluble ...
Predictive Oncology Announces Closing of $21.34 Million Registered Direct Offering Priced At-the-Market under Nasdaq ...
MINNEAPOLIS, June 18, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology” or “the Company”), a knowledge-driven company focused on applying artificial intelligence (“...
Best Penny Stocks to Buy on Robinhood? 3 For Your Morning Watchlist
Are these Robinhood penny stocks the best to watch in 2021? The post Best Penny Stocks to Buy on Robinhood?
Best Biotech Penny Stocks to Buy? Here's 3 That Are Well Funded
Looking for well-funded biotech penny stocks? Check these 3 small-caps out The post Best Biotech Penny Stocks to Buy?
Predictive Oncology Announces $21.34 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
MINNEAPOLIS, June 14, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology” or “the Company”), a knowledge-driven company focused on applying artificial intelligence (“...
4 Penny Stocks With the Potential to Become Top-Notch AI Players
These four penny stocks could get a huge boost from the success of the underlying companies' AI systems going forward. The post 4 Penny Stocks With the Potential to Become Top-Notch AI Players appeared ...
Predictive Oncology Inc. to Attend BIO DIGITAL, the World's Largest Biotech Partnering Experience
MINNEAPOLIS, June 02, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discove...
Predictive Oncology Inc.'s Wholly Owned Subsidiary, TumorGenesis, Partners with Cellevate AB
MINNEAPOLIS, May 20, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology (NASDAQ: POAI), an artificial intelligence driven oncology and drug discovery company, announced today that its wholly owned subsidiary,...
Predictive Oncology Reports Financial Results for Quarter Ended March 31, 2021 and Provides Business Update
MINNEAPOLIS, May 12, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (Nasdaq: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug dis...
Predictive Oncology Inc. Announces Newest Board Member
MINNEAPOLIS, April 27, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discov...
Predictive Oncology Inc. Announces New CEO
MINNEAPOLIS, March 23, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence to personalized medicine and drug discovery, is...
Predictive Oncology Reports Year End 2020 Financial Results, Provides Business Update
MINNEAPOLIS, March 15, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology (NASDAQ: POAI) – Predictive Oncology (Nasdaq: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to ...
POAI ‘s Helomics Division Announces Progress on Milestones for its AI-Driven Model of Ovarian Cancer
Helomics Researchers Complete Key Sequencing Milestones and Focus on AI-Driven Model Building Helomics Researchers Complete Key Sequencing Milestones and Focus on AI-Driven Model Building
Predictive Oncology Announces Closing of $17.6 Million Private Placement Priced At-the-Market
MINNEAPOLIS, Feb. 23, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology” or “the Company”), a knowledge-driven company focused on applying artificial intelligence (“...